Publication | Closed Access

Phase II study of sequential docetaxel (Taxotere®, TXT) and doxorubicin (Dox) as primary chemotherapy (CT) for large operable breast cancer (BC)

Surgical OncologyBreast OncologyMedicinePhase Ii StudyBreast CancerPrimary ChemotherapySequential DocetaxelCancer TreatmentRadiation OncologyOncologyCancer ChemotherapyRadiologyHealth Sciences